Assembly Biosciences Stock Filter Stocks by Fundamentals
| ASMB Stock | USD 13.41 0.08 0.60% |
Assembly Biosciences fundamentals help investors to digest information that contributes to Assembly Biosciences' financial success or failures. It also enables traders to predict the movement of Assembly Stock. The fundamental analysis module provides a way to measure Assembly Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Assembly Biosciences stock.
Assembly | Number of Shares Shorted |
Assembly Biosciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of Assembly Biosciences from analyzing Assembly Biosciences' financial statements. These drivers represent accounts that assess Assembly Biosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Assembly Biosciences' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 537.3M | 214.3M | 100.8M | 45.0M | 51.8M | 49.2M | |
| Enterprise Value | 502.8M | 165.0M | 61.7M | 27.5M | 31.7M | 30.1M |
Assembly Fundamentals
| Return On Equity | -0.99 | ||||
| Return On Asset | -0.34 | ||||
| Operating Margin | (1.75) % | ||||
| Current Valuation | (57.07 M) | ||||
| Shares Outstanding | 5.48 M | ||||
| Shares Owned By Insiders | 32.96 % | ||||
| Shares Owned By Institutions | 13.15 % | ||||
| Number Of Shares Shorted | 42.59 K | ||||
| Price To Earning | (10.58) X | ||||
| Price To Book | 1.95 X | ||||
| Price To Sales | 11.21 X | ||||
| Revenue | 7.16 M | ||||
| Gross Profit | (63.9 M) | ||||
| EBITDA | (64.2 M) | ||||
| Net Income | (61.23 M) | ||||
| Cash And Equivalents | 116.69 M | ||||
| Cash Per Share | 2.41 X | ||||
| Total Debt | 2.34 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 8.31 X | ||||
| Book Value Per Share | 7.50 X | ||||
| Cash Flow From Operations | 22.74 M | ||||
| Short Ratio | 2.20 X | ||||
| Earnings Per Share | (13.38) X | ||||
| Target Price | 36.0 | ||||
| Number Of Employees | 65 | ||||
| Beta | 0.61 | ||||
| Market Capitalization | 73.09 M | ||||
| Total Asset | 137.47 M | ||||
| Retained Earnings | (785.75 M) | ||||
| Working Capital | 94.56 M | ||||
| Current Asset | 68.37 M | ||||
| Current Liabilities | 3.4 M | ||||
| Net Asset | 137.47 M |
About Assembly Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Assembly Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Assembly Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Assembly Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Assembly Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Assembly Biosciences' short interest history, or implied volatility extrapolated from Assembly Biosciences options trading.
Pair Trading with Assembly Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Assembly Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Assembly Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving against Assembly Stock
| 0.6 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
| 0.59 | PFE | Pfizer Inc Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Assembly Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Assembly Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Assembly Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Assembly Biosciences to buy it.
The correlation of Assembly Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Assembly Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Assembly Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Assembly Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Assembly Biosciences Piotroski F Score and Assembly Biosciences Altman Z Score analysis. For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Assembly Stock analysis
When running Assembly Biosciences' price analysis, check to measure Assembly Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assembly Biosciences is operating at the current time. Most of Assembly Biosciences' value examination focuses on studying past and present price action to predict the probability of Assembly Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assembly Biosciences' price. Additionally, you may evaluate how the addition of Assembly Biosciences to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Is Assembly Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Assembly Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (13.38) | Revenue Per Share 1.565 | Quarterly Revenue Growth (1.00) | Return On Assets (0.34) | Return On Equity (0.99) |
The market value of Assembly Biosciences is measured differently than its book value, which is the value of Assembly that is recorded on the company's balance sheet. Investors also form their own opinion of Assembly Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Assembly Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Assembly Biosciences' market value can be influenced by many factors that don't directly affect Assembly Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Assembly Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Assembly Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.